T-cell Depleted Donor Lymphocyte Infusion (DLI)for Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE2
To Determine the Role of Adding Campath-1H or ATG Given In-vivo in Addition to Fludarabine and Low Dose Busulfex on Outcome in Patients Treated With Reduced Intensity Conditioning
- Status
- WITHDRAWN
- Phase
- PHASE3
Efficacy of G-CSF-Priming in Elderly AML Patients
- Status
- UNKNOWN
- Phase
- PHASE4
Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS
- Status
- COMPLETED
- Phase
- PHASE2
Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Natural Killer (NK) Cell Transplantation for AML
- Status
- COMPLETED
- Phase
- NA
Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated by Dynamic Contrast Enhanced Magnetic Resonance (MR) Image
- Status
- UNKNOWN
- Phase
- N/A
An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
- Status
- COMPLETED
- Phase
- N/A
Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel
- Status
- COMPLETED
- Phase
- N/A
WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE2
All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Standard vs. Reduced-Intensity Conditioning in Patients With Acute Myeloid Leukemia in First Remission
- Status
- TERMINATED
- Phase
- PHASE3
Risk-Adapted Therapy of Acute Myeloid Leukemia of Adults (18-60 Years) According to the Cytogenetic Result
- Status
- COMPLETED
- Phase
- PHASE3
HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE3